相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
Ingo Kleiter et al.
NEUROTHERAPEUTICS (2016)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein et al.
JAMA NEUROLOGY (2015)
DoesMOGIg-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Scott S. Zamvil et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension
Jun-ichi Kira et al.
BMC NEUROLOGY (2014)
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Corinna Trebst et al.
JOURNAL OF NEUROLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
Sara J. Ireland et al.
JAMA NEUROLOGY (2014)
Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
So-Young Huh et al.
JAMA NEUROLOGY (2014)
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica Multicenter Study of Treatment Efficacy
Maureen A. Mealy et al.
JAMA NEUROLOGY (2014)
Immunology of neuromyelitis optica: a T cell-B cell collaboration
Meike Mitsdoerffer et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
Sven Jarius et al.
BRAIN PATHOLOGY (2013)
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
Philippe Cabre et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Joanna Kitley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Su-Hyun Kim et al.
JAMA NEUROLOGY (2013)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Ingo Kleiter et al.
ARCHIVES OF NEUROLOGY (2012)
Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica
Bhupendra O. Khatri et al.
JOURNAL OF CLINICAL APHERESIS (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica
Kai-Chen Wang et al.
MEDICAL HYPOTHESES (2011)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis
Sakhina Begum-Haque et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
J. Shimizu et al.
NEUROLOGY (2010)
Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo
Monika Bradl et al.
ANNALS OF NEUROLOGY (2009)
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
Akiyuki Uzawa et al.
JOURNAL OF NEUROLOGY (2009)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S. Jarius et al.
BRAIN (2008)
Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis
Sakhina Begum-Haque et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Glatiramer acetate treatment in Devic's neuromyelitis optica
R Bergamaschi
BRAIN (2003)
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
G Comi et al.
ANNALS OF NEUROLOGY (2001)
分享论文
